Novo Nordisk’s new diabetes pill, Rybelsus, will be covered by Express Scripts Holding Co, one of the largest U.S. pharmacy benefit managers, the Danish drugmaker said on Friday. Pharmacy benefit…Read More
Nano-X Imaging (Nanox), an imaging technology company based out of Israel, has announced the completion of a funding round worth $26 million. The company has now raised $55 million overall….Read More
Medical imaging technology firm NANO-X IMAGING (Nanox) has secured $26m in the latest funding round that saw participation from Foxconn, a Taiwanese electronics manufacturer, to support the development, commercialisation, and…Read More
AngioDynamics has commenced a pilot study to assess performance and clinical outcomes of the Auryon atherectomy system. The PATHFINDER I: Post-Market Registry has been launched for the assessment of the…Read More
Mojo Vision has secured breakthrough device designation from the US Food and Drug Administration (FDA) to develop a smart contact lens. The company is currently involved in the development of…Read More
Israeli medical imaging company Nanox Imaging Ltd said on Thursday it raised $26 million with the participation of strategic investor Foxconn, bringing the total funds raised for its Nanox System…Read More
Bayer (BAYGn.DE) is close to settling more than 75,000 cancer claims related to its Roundup herbicide, mediator Ken Feinberg told Bloomberg in an interview, saying he was “cautiously optimistic” a…Read More
Germany’s drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence of benefits, in a setback to the drugmaker…Read More
Eli Lilly and Co (LLY.N) aims to announce roughly one $1 billion to $5 billion deal every quarter in 2020, its chief financial officer told Reuters, as the U.S. drugmaker…Read More
KENILWORTH, N.J.–(BUSINESS WIRE)– Merck & Company (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all…Read More
Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that it has entered into a strategic transaction with Bonus BioGroup Ltd….Read More
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including…Read More
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for APD418, a β3-adrenergic receptor (AdrR) antagonist and cardiac myotrope, in development for the…Read More
INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, and Medesole, a leading supplier of healthcare products in India and the Middle East, today…Read More
Neuroptika, a privately held biotechnology company focused on the development of novel regenerative treatments for ophthalmic diseases, today announced that the first patient was enrolled in a Phase 2 clinical…Read More
